A global health care leader dedicated to enhancing human health around the world, Weill Cornell Medicine has entered into an agreement with Top Spring Huaxia Medical Investment to help it develop a modern outpatient diagnostic clinic in China.

Weill Cornell Medicine will collaborate with Top Spring Huaxia Medical, a diversified enterprise with expertise in property development, health care and finance, to help it create the clinic located in Shenzhen, China’s fourth-largest city. One of the few American academic medical institutions to engage with Chinese health care, Weill Cornell Medicine will leverage its expertise in clinical care and continuing medical education to provide insights that will inform the planning process for the clinic. A ceremony on Nov. 4 in Beijing, attended by officials from Weill Cornell Medicine and Top Spring Huaxia Medical, celebrated the agreement’s signing.

Working with NewYork-Presbyterian Hospital, one of the nation’s most comprehensive health care delivery networks, Weill Cornell Medicine will help lead a feasibility study that will determine how best to structure the clinic and what medical specialties and diagnostic capabilities to deliver. As currently envisioned, the clinic will be able to provide advanced patient care by incorporating Western medical standards, practice guidelines and innovations, and Weill Cornell Medicine will provide leadership in the standards and protocols used. Weill Cornell Medicine also will help establish a continuing medical education center for practicing physicians, which will encompass an entire floor of the facility. There, doctors practicing in Shenzhen and in other regions of China will learn about the latest Western practice techniques and standards across multiple specialties.

“Weill Cornell Medicine has a proud history of leading the way in medicine, providing our patients with the finest care,” said Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine. “This commitment extends beyond our national doorstep; it is our responsibility as doctors and scientists to share the latest medical innovations globally. We are proud to collaborate with Top Spring Huaxia Medical to realize this vision, which will benefit many patients in Shenzhen.”

“Weill Cornell Medicine has established a successful model for delivering exemplary care – from primary and specialty care to imaging – to our patients throughout New York City,” said Dr. Michael G. Stewart, vice dean of Weill Cornell Medicine, and professor and chairman of the Department of Otolaryngology – Head and Neck Surgery. “We are deeply committed to extending this vital work around the world. By offering our medical expertise and technology to our new partners at Top Spring Huaxia Medical, we will bring a new model of health care to the people of Shenzhen.”

“Our cooperation with Weill Cornell Medicine will be very constructive to the development of medical technology, management and medical education in China,” said Shao Chunwei, chairman of Top Spring Huaxia Medical Investment. “We welcome Weill Cornell Medicine’s presence in China, and we are confident that the cooperation we have with Weill Cornell Medicine will be a fruitful one.”

Weill Cornell Medicine’s collaboration with Top Spring Huaxia Medical in Shenzhen is the latest example of the institution’s commitment to global health. It has established clinical and research programs on every continent except Antarctica; and through Weill Cornell Medical College in Qatar, Cornell University is the first in the United States to offer a medical degree oversees. Weill Cornell Medicine forged an affiliation with Bugando Medical Centre and the Weill Bugando University College of Health Sciences in Mwanza, Tanzania. And through a partnership with The Open Medical Institute, Weill Cornell Medicine faculty teach Western medical knowledge and train top foreign doctors during seminars hosted in Salzburg, Austria.